Harmony Biosciences Holdings, Inc. · Biotechnology

HRMYHarmony Biosciences Holdings, Inc.

Reports 2026-11-04 Pre-market · WedReaction day 11-04upcoming

Before the print · expectationsReports today

No past prints on file yet.

Pricing going in · as of the 10-30 close

−2.2%Move over the last 20 sessionsLast 5 sessions +7.3%
—vs sector (XLV)XLV over the same window —
—Forward P/EConsensus: not available

What the record doesn't tell you

Which way does HRMY go on 11‑04?

  • Model lean for 11-04, and the evidence behind it
  • Move band, P10 – P90
  • Last 8 prints, quarter by quarter
  • Peers that already reported, and how they traded
Start 30-day free trialFull access · no card requiredHave an account? Sign inThe lean freezes the night before the print.

The print · 8-K and callupcoming · 2026-11-04 · Pre-market

Revenue$269M
est. —
EPS—
est. —
Guidance · FY revenue$1.00B–$1.04B
vs consensus −0.6% · Consensus $1.03B

Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →

Harmony Biosciences earnings preview: what the record says

Harmony Biosciences (HRMY) is scheduled to report earnings on Nov 4, 2026, before the open.

Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.

HRMY earnings: key questions

When is HRMY's next earnings date?

Harmony Biosciences is scheduled to report on Nov 4, 2026, before the open.